Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BioCorRx Inc (QB) | BICX | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.47978 | 15:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.47978 | 0.47978 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.45 - 2.22 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.47978 | USD |
BioCorRx Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.13M | 8.50M | 1.45M | 89k | -3.77M | -0.44 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioCorRx (QB) News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BICX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6708 | 0.70 | 0.45 | 0.4898437 | 4,736 | -0.19102 | -28.48% |
| 1 Month | 0.78 | 0.81 | 0.45 | 0.5807805 | 2,451 | -0.30022 | -38.49% |
| 3 Months | 0.90 | 1.50 | 0.45 | 0.8182021 | 2,117 | -0.42022 | -46.69% |
| 6 Months | 0.90 | 1.50 | 0.45 | 0.8210229 | 1,916 | -0.42022 | -46.69% |
| 1 Year | 1.69 | 2.22 | 0.45 | 1.09 | 1,864 | -1.21 | -71.61% |
| 3 Years | 4.85 | 7.50 | 0.2177 | 2.42 | 2,002 | -4.37 | -90.11% |
| 5 Years | 4.25 | 8.10 | 0.155 | 2.52 | 2,236 | -3.77 | -88.71% |
BioCorRx (QB) Description
| BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Company's majority owned subsidiary BioCorRx Pharmaceuticals Inc. is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Specifically, the Company is developing an implantable naltrexone (BICX104) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com. |
